Acura Pharmaceuticals Inc (ACUR)

1.91
0.06 3.00
NASDAQ : Health Care
Prev Close 1.97
Open 1.93
Day Low/High 1.87 / 1.96
52 Wk Low/High 1.61 / 4.15
Volume 2.71K
Avg Volume 37.70K
Exchange NASDAQ
Shares Outstanding 11.83M
Market Cap 24.38M
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Acura Pharmaceuticals (ACUR) Stock Spikes on Development Deal with Bayer Healthcare

Acura Pharmaceuticals (ACUR) Stock Spikes on Development Deal with Bayer Healthcare

Acura Pharmaceuticals (ACUR) shares are up over 30% after the company entered into a licensing and development deal with Bayer Healthcare (BAYRY) for its IMPEDE technology.

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.

3 Stocks Advancing The Drugs Industry

3 Stocks Advancing The Drugs Industry

TheStreet highlights 3 stocks that pushed the Drugs industry

3 Drugs Stocks Moving The Industry Upward

3 Drugs Stocks Moving The Industry Upward

TheStreet highlights 3 stocks that pushed the Drugs industry

Acura Pharmaceuticals Inc Stock Downgraded (ACUR)

Acura Pharmaceuticals Inc Stock Downgraded (ACUR)

Acura Pharmaceuticals (Nasdaq:ACUR) has been downgraded by TheStreet Ratings from from a hold to sell.

Faruqi & Faruqi, LLP Launches An Investigation Against Acura Pharmaceuticals, Inc. (ACUR) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors

Faruqi & Faruqi, LLP Launches An Investigation Against Acura Pharmaceuticals, Inc. (ACUR) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Acura Pharmaceuticals, Inc.

4 Stocks Under $10 Moving Higher

4 Stocks Under $10 Moving Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

Traders savvy enough to follow the low-priced names and trade them with discipline and sound risk management are banking ridiculous coin on a regular basis.

5 Stocks Poised for Breakouts

5 Stocks Poised for Breakouts

These stocks look ready to break out and trade higher from current levels.

4 Stocks Under $5 Moving Higher

4 Stocks Under $5 Moving Higher

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Acura Pharmaceuticals Management Discusses Q2 2012 Results - Earnings Call Transcript

Acura Pharmaceuticals Management Discusses Q2 2012 Results - Earnings Call Transcript

Acura Pharmaceuticals Management Discusses Q2 2012 Results - Earnings Call Transcript

8 Stocks Under $10 Moving Higher

8 Stocks Under $10 Moving Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

7 Stocks Under $10 Moving Higher

Stocks making large-percentage moves are favorites among short-term traders who want to capture some of that massive volatility.

Acura Stock Soars (ACUR)

Shares of Acura Pharmaceuticals (Nasdaq:ACUR) have taken a tremendous swing upward. The stock is trading at $3.57 as of 2:01 p.m. ET, 20.6% above Thursday's closing price of $2.96. Volume is at 421,729, 4.4 times the daily average of 94,900.

Acura Stock Soars (ACUR)

Shares of Acura Pharmaceuticals (Nasdaq:ACUR) have taken a tremendous swing upward. The stock is trading at $3.12 as of 11:54 a.m. ET, 21.4% above Friday's closing price of $2.57. Volume is at 104,912, 0.3 times the daily average of 318,000.

Acura Pharmaceuticals Inc. Stock Upgraded (ACUR)

Acura Pharmaceuticals (Nasdaq:ACUR) has been upgraded by TheStreet Ratings from a sell to hold.

Pfizer, Pain Therapeutics Drug Rejected by FDA

Pfizer and Pain Therapeutics have been trying to get Remoxy, a tamper-resistant painkiller, approved for three years.

Small-Cap Spotlight: Dex One, Acura Pharma

Shares of Dex One surge after the company partners with Google, while Acura Pharmaceuticals gets a lift from positive regulatory news.

Pfizer, Acura Painkiller Approved by FDA

The Pfizer/Acura painkiller Oxecta consists of the narcotic oxycodone combined with ingredients to make the drug resistant to tampering and abuse.

Pfizer And Acura Announce FDA Approval Of Oxectatm (Oxycodone HCL, USP) CII

Pfizer Inc. (NYSE: PFE) and Acura Pharmaceuticals Inc.

A Busy Week for Six Biotech Stocks

Acura, Pain Therapeutics and Fibrocell deal with FDA approval decisions while Curis presents new cancer drug data.

Pfizer Adds New Partners Through King Buy

Pain Therapeutics and Acura Pharmaceuticals will partner with Pfizer once the King Pharma acquisition closes.